Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Sanofi Former
Online Auction Featuring Pharmaceutical Packaging & Processing Equipment Formerly of Sanofi! Cleveland, OH

Starting: Apr 24th, 2023 7:00am EDT

Ending: Apr 27th, 2023 10:00am EDT

Immediately Accepting Bids
Neoleukin
Online Auction Featuring Late Model Lab/R&D Equipment No Longer Required by Neoleukin! Seattle, WA.

Starting: Apr 25th, 2023 7:00am PDT

Ending: Apr 26th, 2023 8:00am PDT

Immediately Accepting Bids
Finch Therapeutics
Online Auction of Late Model R&D Lab & Pilot Process Equipment Finch Therapeutics! Somerville, MA.

Starting: Apr 18th, 2023 7:00am EDT

Ending: Apr 19th, 2023 10:00am EDT

Immediately Accepting Bids
OM Diagnostics
Online Auction Featuring R&D Equipment Surplus To Continuing Operations Of OM Diagnostic Laboratories! San Diego, CA.

Starting: Apr 11th, 2023 7:00am PDT

Ending: Apr 12th, 2023 9:00am PDT

Immediately Accepting Bids
Calithera
Online Auction Featuring Quality Lab Equipment From Calithera, A Bay Area Clinical Stage Biotech! Hayward, CA.

Starting: Apr 5th, 2023 7:00am PDT

Ending: Apr 6th, 2023 8:00am PDT

Immediately Accepting Bids
TCR2
Online Auction Featuring Surplus Lab Equipment & Consumables From TCR2 Therapeutics! Cambridge, MA.

Starting: Mar 30th, 2023 7:00am EDT

Ending: Mar 31st, 2023 12:00pm EDT

Immediately Accepting Bids
Invitae
Online Auction Featuring State of the Art BioPharma Lab Equipment From Invitae’s Boulder, Golden & Louisville Sites!

Starting: Mar 28th, 2023 7:00am MDT

Ending: Mar 29th, 2023 9:00am MDT

Immediately Accepting Bids
PSS (Pre 2023)
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Mar 20th, 2023 7:00am PDT

Ending: Mar 21st, 2023 8:00am PDT

Immediately Accepting Bids
Akorn Pharmaceuticals
Sale #2. Global Online Auction Featuring Pharmaceutical Lab & Process Equipment Formerly of Akorn Pharmaceuticals. Cranbury, NJ.

Starting: Mar 6th, 2023 7:00am EDT

Ending: Mar 7th, 2023 10:00am EDT

Immediately Accepting Bids
ANI Pharmaceuticals
Online Auction Featuring Quality Processing, Packaging and Lab Equipment from ANI Pharmaceuticals!  Oakville, ON, Canada.

Starting: Feb 28th, 2023 7:00am EDT

Ending: Mar 1st, 2023 10:00am EDT

Immediately Accepting Bids
Multi Lab Auction (Rigel, SWL, Invitae)
Online Auction Featuring Surplus Lab Equipment From Rigel, Sonoma Lab Works and Invitae! Hayward, CA.

Starting: Feb 22nd, 2023 7:00am PDT

Ending: Feb 23rd, 2023 8:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.